Delivery of therapeutic genes is essential for gene therapy. Adeno-associated viruses (AAVs) are a prime vector for carrying ...

This episode is brought to you by the “Things You Don’t Need to Know” podcast. This show will teach you about things you ...

Akeega, an oral dual mechanism therapy pairing niraparib with abiraterone, has won a positive committee opinion in Europe for ...

Ambry Genetics, a leader in clinical genomic testing, and now a wholly owned subsidiary of Tempus AI, Inc. , today announced its contribution to new research leveraging Multiplexed Assays of Variant ...

Amgen Inc. (AMGN) is a leading biotechnology company headquartered in Thousand Oaks, California. It specializes in the discovery, development, manufacturing, and delivery of innovative human ...

Making diagrams saves time, reduces ambiguity, and leaves a memorable impression on examiners. Check tips shared by the ...

Pregnancy loss remains common around the world. About 15 percent of known pregnancies end in miscarriage, although the true number is likely much higher, since many pregnancies are lost before they ...

Bats, critical reservoirs of viruses with significant cross-species spillover risks, have long been understudied in the ...

J&J receives CHMP positive opinion for Akeega to treat patients with metastatic hormone-sensitive prostate cancer with BRCA1/2 mutations: Beerse, Belgium Monday, February 2, 2026, ...

AMPLITUDE is the first clinical trial to evaluate potential therapies for patients with mHSPC and known HRR gene alterations, with positive results supporting the niraparib-based combination regimen a ...

Chugai files regulatory application with MHLF for additional indication of Tecentriq to treat adjuvant therapy for MRD-positive bladder cancer: Tokyo Thursday, January 29, 2026, 0 ...